Research topic: Health economics of biological agents in Australia.
Faculty of Medicine, Sydney University, Sydney, Australia.
Li-Chin
LC
Wang
Concord Repatriation Hospital, Gastroenterology and Liver Services, Sydney, Australia.
Glen
G
Collins
Concord Repatriation Hospital, Gastroenterology and Liver Services, Sydney, Australia.
Crispin
C
Corte
Concord Repatriation Hospital, Gastroenterology and Liver Services, Sydney, Australia.
Peter
P
Katelaris
Concord Repatriation Hospital, Gastroenterology and Liver Services, Sydney, Australia.
Rupert
R
Leong
D000068879:Adalimumab / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D001315:Australia / Q000453:epidemiology; D001685:Biological Factors / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs / Q000706:statistics & numerical data* / Q000639:trends; D005102:Health Expenditures / Q000706:statistics & numerical data* / Q000639:trends; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000191:economics*; D000069285:Infliximab / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D055656:Prescriptions / Q000191:economics* / Q000706:statistics & numerical data*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D001685:Biological Factors; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab